Home / Fact sheets / France / Colorectal qualitative data
Check also the following factsheets: France, Breast, Cervical
Country fact sheet: France
COLORECTAL CANCER SCREENING PROGRAMME
| Reporting year for qualitative data: | 2016 |
| Source of qualitative data: | Other (EU Report 2017) |
Organization of screening | |
| An individual/team/institution responsible to coordinate the programme: | Yes |
| Dedicated budget for screening programme: | Yes |
| Documented cancer screening policy: | Yes |
| Nature of documentation of the policy: | Recommendation |
| Year programme was initiated: | 2002 |
| Programme introduction was preceded by a pilot: | - |
| Screening tests provided free of charge: | Yes |
| Diagnostic tests provided free of charge: | No |
| Treatment services provided free of charge: | - |
Information system and data collection | |
| System that collects data: | Individual & Aggregated |
| • Identification of eligible population: | - |
| • Screening participation: | - |
| • Screening test results: | - |
| • Further assessment: | - |
| • Final pathology diagnosis: | - |
| • Cancer staging: | - |
| • Treatment: | - |
| The information system exists at national or sub-national level: | Individual: Unknown Aggregated: Unknown |
| The information system collects data outside the programme (opportunistic screening/private sector): | - |
| Cancer screening data is linked with population-based cancer registry (PBCR): | Yes |
Screening protocol | |
| A screening protocol or guideline: | - |
| Year of published/updated protocol: | - |
| Target age (min-max) and screening interval [months] for each test: | FIT (50-74 years / [24 months]) gFOBT (50-74 years / [24 months]) |
Invitations for screening and further assessment | |
| Initiatives to create population awareness by the Health Ministry/Health Authority: | - |
| Invitations to eligible population: | Yes |
| Source of the eligible individuals identified: | |
| Method of invitation: | Letter |
| Screening kit included with the invitation: | No |
| Screen positive individuals actively contacted for further assessment: | Yes |
| Individuals with a precancer or cancer diagnosis actively contacted: | - |
Quality Assurance (QA) of screening activities | |
| Documented standard operating procedure/policy for QA: | Yes |
| An individual/team/institution responsible for QA: | Yes |
| Accreditation of endoscopy units: | - |
| Accreditation of pathology services: | - |
| Documented performance indicators: | Yes |
| Reference standards for performance indicators: | - |
| Evaluation reports published in the last five years: | Yes |
Performance indicators | |
| Reporting year for quantitative data: | 2016 |
| Source of quantitative data: | Report (EU Report 2017) |
| FIT | gFOBT | Sigmoidoscopy | Colonoscopy | |
| Target age and regional limitation if applicable: | 50-74 (Calvados) | 50-74 | ||
| Invitation coverage (%): | 88.2 | 97.0 | ||
| Participation rate (%): | 22.8 | 24.4 | ||
| Examination coverage (%): | 20.1 | 23.7 | ||
| Completeness of data related to screening results (%): | 99.2 | 97.9 | ||
| Completeness of data related to information about attendance to colonoscopy assessment (%): | 100.1 | 100.0 | ||
| Further assessment (diagnosis colonoscopy) rate (%): | 3.3 | 2.2 | ||
| Further assessment participation rate (%): | 87.9 | 84.0 | ||
| Detection rate of adenomas (x 1000): | 10.7 | 6.1 | ||
| Detection rate of advanced adenomas (x 1000): | 6.0 | 3.6 | ||
| Detection rate of colorectal cancers (x 1000): | 1.8 | 0.6 | ||
| Positive Predictive Value of further assessment to detect adenomas (%): | 37.5 | 33.6 | ||
| Positive Predictive Value of further assessment to detect advanced adenomas (%): | 21.2 | 19.8 | ||
| Positive Predictive Value of further assessment to detect colorectal cancers (%): | 6.3 | 3.5 | ||
| More quantitative data (Male - 2012/gFOBT) | ||||
| More quantitative data (Women - 2012/gFOBT) | ||||
| More quantitative data (Calvados: Male - 2012/FIT) | ||||
| More quantitative data (Calvados: Women - 2012/FIT) |
Check also the following factsheets: France, Breast, Cervical